1
/
of
0
FDA Drug Approval, N050609, ERYTHROCIN
FDA Drug Approval, N050609, ERYTHROCIN
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 050609
Company: HOSPIRA
Drug Name: ERYTHROCIN
Active Ingredients: ERYTHROMYCIN LACTOBIONATE
Strength: EQ 1GM BASE/VIAL
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 09/24/1986
Marketing Status: Discontinued
Submission Classification: Type 3 - New Dosage Form
Company: HOSPIRA
Drug Name: ERYTHROCIN
Active Ingredients: ERYTHROMYCIN LACTOBIONATE
Strength: EQ 1GM BASE/VIAL
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 09/24/1986
Marketing Status: Discontinued
Submission Classification: Type 3 - New Dosage Form
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details